CJC-1295 + Ipamorelin + Retatrutide

Cjc 1295 + Ipamorelin + Retatrutide

Ask about this stack

Get a grounded answer across clinical evidence, community patterns, and risks.

Ask AI →

25

authors mention this stack

16

ran the components concurrently

CJC-1295 + Ipamorelin + Retatrutide (CJC-1295 + Ipamorelin + Retatrutide) appears in 25 author journeys (16 as actual concurrent use). Common goals: Cycle peptides for weight loss; body recomposition; Weight loss, healing, recovery, and sleep. Typical doses reported: Retatrutide 1mg, CJC-1295 200mcg, Ipamorelin 200mcg. Reported side effects include: food cravings when dose was at 2mg (resolved after upping to 4mg) Research: 1 study discusses two or more of these components together (1 clinical); the components appear across 46 studies in total.

Research support

1 research study discusses two or more of these components together (1 clinical). Per-component literature:

CJC-1295 3 studies (1 clinical)
Ipamorelin 7 studies (1 clinical)
Retatrutide 37 studies (26 clinical)

PubMed/PMC articles mentioning each compound in title or abstract.

Typical doses reported

Retatrutide 1mg
Cjc 1295 200mcg
Ipamorelin 200mcg

Community-reported doses are not medical guidance.

How people are running it

13

Currently running

5

Planning to run

4

Recommended / discussed

3

Ran in the past

1

Unclear

What people use it for

Cycle peptides for weight lossbody recompositionWeight loss, healing, recovery, and sleepTo treat poor sleep quality worsened by Retatrutideweight loss and resolving obstructive sleep apneaMuscle loss prevention and body recomp.

Sample reported outcomes

  • ✓ Did not help improve sleep quality
  • ✓ significant weight loss, stopped snoring, off CPAP machine
  • ✓ Initially resulted in great sleep and good feelings during workouts.
  • ✓ Restoration of deep sleep and steady reduction in blood pressure.
  • ✓ Not much effect, cjc/ipa caused some water retention
  • ✓ Significant recovery in injuries and increased weight lifting capacity; however, no weight loss observed from Retatrutide after 6 weeks and no skin improvement observed from Glow.
  • ✓ Weight is steadily dropping
  • ✓ Allowed the author to eat decently/properly again while on Retatrutide

Self-reported community experiences, not verified results.

Sample reported side effects

  • ⚠ food cravings when dose was at 2mg (resolved after upping to 4mg)
  • ⚠ Severe joint pain after 5-6 weeks that made the author feel like they were regressing to a pre-peptide state.
  • ⚠ None reported for this period.
  • ⚠ Retained 2 lbs of water
  • ⚠ Soreness at the KLOW injection site (resolving within 24 hours) and occasional bruising.
  • ⚠ Skin sensitivity, anxiety, and elevated heart rate (linked to Retatrutide titration); sleep disruption when CJC/Ipamorelin was pinned before bed
  • ⚠ Ipamorelin increased appetite significantly, making it feel like Retatrutide had stopped working.
  • ⚠ Retatrutide: sensitive gag reflex, coldness